Abstract
Background The extent to which physical activity attenuates the detrimental effects of sugar (SSBs)- or artificially-sweetened beverages (ASBs) on the risk of cardiovascular disease is unknown.
Methods We used Cox proportional-hazards models to calculate hazard ratios and 95% confidence interval [HR (CI)] between SSB or ASB intake and physical activity with cardiovascular disease risk among 65,730 women in the Nurses’ Health Study (1980-2016) and 39,418 men in the Health Professional’s Follow-up Study (1986-2016), who were free from chronic diseases at baseline. SSBs and ASBs were assessed every 4-years and physical activity biannually.
Results A total of 13,269 cardiovascular events were ascertained during 3,001,213 person-years of follow-up. Compared with those that never/rarely consumed SSBs or ASBs, HR and 95% CI for cardiovascular disease for participants consuming ≥2 servings/day were 1.21 (95% CI,1.12 to 1.32; P-trend<0.001) and 1.03 (95% CI, 0.97 to 1.09; P-trend=0.06), respectively. In the joint analyses, for participants meeting and not meeting physical activity guidelines (<7.5 vs ≥7.5 MET-h/week) as well as consuming ≥2 servings/day of SSBs or ASBs, the HRs for cardiovascular disease were 1.15 (95% CI, 1.08 to 1.23) and 0.96 (95% CI, 0.91 to 1.02), and 1.47 (95% CI, 1.37 to 1.57) and 1.29 (95% CI, 1.22 to 1.37) respectively, compared with participants who met physical activity guidelines and never/rarely consumed these beverages. Similar patterns were observed when coronary heart disease and stroke were analyzed.
Conclusions Our findings suggest that among physically active participants, higher SSB intake, but not ASBs, is associated with a higher cardiovascular risk. Our results support current recommendations to limit the intake of SSB and maintain adequate physical activity levels.
What is new?
Consumption of sugar- or artificially-sweetened beverages and physical activity are independently associated with cardiovascular disease; nevertheless, the role that physical activity plays in the associations between sugar- and artificially-sweetened beverages consumption and cardiovascular disease warrants further analysis since physical activity could offset the health risk that would have been induced by their consumption.
In two US cohorts, not meeting physical activity guidelines jointly with a greater intake of sugar- or artificially-sweetened beverages was associated with a higher risk of cardiovascular disease; however, even when individuals were physically active, higher consumption of sugar-sweetened beverages was associated with a higher cardiovascular risk.
What are the clinical implications?
Our results provide further evidence of the intake of sugar-sweetened beverages and low physical activity as factors negatively impacting cardiovascular health.
Our results support public health recommendations and policies to limit the intake of sugar-sweetened beverages and meet and maintain adequate physical activity levels.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Not applicable.
Funding Statement
The research reported in this manuscript were supported by National Institutes of Health grants UM1 CA186107, U01 CA167552, R01 HL034594, R01 HL088521, and R01 HL35464. Additionally, this work was supported by grant T32 DK007703-26 from the National Institute of Diabetes and Digestive and Kidney Diseases and the Harvard Chan Yerby Fellowship at Harvard T.H. Chan School of Public Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The protocol was approved by the institutional review board of Brigham and Women's Hospital and Harvard T.H. Chan School of Public Health. All participants gave informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
